WASHINGTON (dpa-AFX) - Shares of Edwards Lifesciences (EW) have come under pressure during trading on Monday, with the medical products maker sliding by 1 percent.
The drop by Edwards comes after the company agreed to acquire privately held Valtech Cardio $340 million in cash and stock and the potential for up to $350 million in additional milestone payments over the next 10 years.
Copyright RTT News/dpa-AFX